Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2005 Feb;90(2):132–137. doi: 10.1136/adc.2003.043935

Congenital hypothyroidism: no adverse effects of high dose thyroxine treatment on adult memory, attention, and behaviour

B Oerbeck 1, K Sundet 1, B Kase 1, S Heyerdahl 1
PMCID: PMC1720264  PMID: 15665163

Abstract

Background: In congenital hypothyroidism (CH) it has been questioned whether high dose thyroxine replacement therapy has detrimental effects on memory, attention, and behaviour.

Aims: To describe memory, attention, and behaviour problems in young adults with CH, and to study possible negative effects of high dose thyroxine replacement therapy.

Methods: A cohort based follow up study of 49 young adults (mean age 20 years) with early treated CH, and sibling controls (n = 41).

Results: Controlled for age and sex, the CH group attained significantly lower scores than sibling controls on some tests of memory (Wechsler Logical Memory part II: 12.9 versus 17.8; difference 5.2, 95% CI 3.6 to 6.8) and attention (Wechsler Freedom From Distractibility factor: 95.6 versus 104.8; difference 9.9, 95% CI 6.4 to 13.4). They rated themselves with more behaviour problems than did sibling controls (52.7 versus 44.7; difference –7.6, 95% CI –11.2 to –4.0) on the Achenbach Self Report. A high thyroxine starting dose, high serum thyroxine treatment levels during the first six childhood years, and high levels at assessment had no adverse effects on outcome measures at age 20. On the contrary, the results suggest better outcome with higher childhood treatment levels.

Conclusions: Long term outcome revealed deficits in some aspects of memory, attention, and behaviour in young adults with CH relative to sibling controls. No adverse effects of high dose thyroxine therapy were found on measures of memory, attention, and behaviour problems.

Full Text

The Full Text of this article is available as a PDF (217.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bongers-Schokking J. J., Koot H. M., Wiersma D., Verkerk P. H., de Muinck Keizer-Schrama S. M. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr. 2000 Mar;136(3):292–297. doi: 10.1067/mpd.2000.103351. [DOI] [PubMed] [Google Scholar]
  2. Derksen-Lubsen G., Verkerk P. H. Neuropsychologic development in early treated congenital hypothyroidism: analysis of literature data. Pediatr Res. 1996 Mar;39(3):561–566. doi: 10.1203/00006450-199603000-00028. [DOI] [PubMed] [Google Scholar]
  3. Dubuis J. M., Glorieux J., Richer F., Deal C. L., Dussault J. H., Van Vliet G. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment. J Clin Endocrinol Metab. 1996 Jan;81(1):222–227. doi: 10.1210/jcem.81.1.8550756. [DOI] [PubMed] [Google Scholar]
  4. Heyerdahl S., Kase B. F., Lie S. O. Intellectual development in children with congenital hypothyroidism in relation to recommended thyroxine treatment. J Pediatr. 1991 Jun;118(6):850–857. doi: 10.1016/s0022-3476(05)82194-8. [DOI] [PubMed] [Google Scholar]
  5. Heyerdahl S., Kase B. F., Stake G. Skeletal maturation during thyroxine treatment in children with congenital hypothyroidism. Acta Paediatr. 1994 Jun;83(6):618–622. doi: 10.1111/j.1651-2227.1994.tb13092.x. [DOI] [PubMed] [Google Scholar]
  6. Heyerdahl S. Treatment variables as predictors of intellectual outcome in children with congenital hypothyroidism. Eur J Pediatr. 1996 May;155(5):357–361. doi: 10.1007/BF01955261. [DOI] [PubMed] [Google Scholar]
  7. Heyerdahl Sonja, Oerbeck Beate. Congenital hypothyroidism: developmental outcome in relation to levothyroxine treatment variables. Thyroid. 2003 Nov;13(11):1029–1038. doi: 10.1089/105072503770867200. [DOI] [PubMed] [Google Scholar]
  8. Hindmarsh P. C. Optimisation of thyroxine dose in congenital hypothyroidism. Arch Dis Child. 2002 Feb;86(2):73–75. doi: 10.1136/adc.86.2.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hrytsiuk Ihor, Gilbert Ruth, Logan Stuart, Pindoria Sima, Brook Charles G. D. Starting dose of levothyroxine for the treatment of congenital hypothyroidism: a systematic review. Arch Pediatr Adolesc Med. 2002 May;156(5):485–491. doi: 10.1001/archpedi.156.5.485. [DOI] [PubMed] [Google Scholar]
  10. Kooistra L., Stemerdink N., van der Meere J., Vulsma T., Kalverboer A. F. Behavioural correlates of early-treated congenital hypothyroidism. Acta Paediatr. 2001 Oct;90(10):1141–1146. doi: 10.1080/080352501317061549. [DOI] [PubMed] [Google Scholar]
  11. Kooistra L., van der Meere J. J., Vulsma T., Kalverboer A. F. Sustained attention problems in children with early treated congenital hypothyroidism. Acta Paediatr. 1996 Apr;85(4):425–429. doi: 10.1111/j.1651-2227.1996.tb14054.x. [DOI] [PubMed] [Google Scholar]
  12. Leneman M., Buchanan L., Rovet J. Where and what visuospatial processing in adolescents with congenital hypothyroidism. J Int Neuropsychol Soc. 2001 Jul;7(5):556–562. doi: 10.1017/s1355617701755038. [DOI] [PubMed] [Google Scholar]
  13. Oerbeck Beate, Sundet Kjetil, Kase Bengt F., Heyerdahl Sonja. Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics. 2003 Oct;112(4):923–930. doi: 10.1542/peds.112.4.923. [DOI] [PubMed] [Google Scholar]
  14. Rovet J. F. Congenital hypothyroidism: long-term outcome. Thyroid. 1999 Jul;9(7):741–748. doi: 10.1089/thy.1999.9.741. [DOI] [PubMed] [Google Scholar]
  15. Rovet J. F., Ehrlich R. M. Long-term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr. 1995 Mar;126(3):380–386. doi: 10.1016/s0022-3476(95)70452-3. [DOI] [PubMed] [Google Scholar]
  16. Rovet J. F., Ehrlich R. Psychoeducational outcome in children with early-treated congenital hypothyroidism. Pediatrics. 2000 Mar;105(3 Pt 1):515–522. doi: 10.1542/peds.105.3.515. [DOI] [PubMed] [Google Scholar]
  17. Rovet J. F., Hepworth S. L. Dissociating attention deficits in children with ADHD and congenital hypothyroidism using multiple CPTs. J Child Psychol Psychiatry. 2001 Nov;42(8):1049–1056. doi: 10.1111/1469-7610.00804. [DOI] [PubMed] [Google Scholar]
  18. Rovet J. F., Hepworth S. Attention problems in adolescents with congenital hypothyroidism: a multicomponential analysis. J Int Neuropsychol Soc. 2001 Sep;7(6):734–744. doi: 10.1017/s135561770176609x. [DOI] [PubMed] [Google Scholar]
  19. Rovet Joanne F. Congenital hypothyroidism: an analysis of persisting deficits and associated factors. Child Neuropsychol. 2002 Sep;8(3):150–162. doi: 10.1076/chin.8.3.150.13501. [DOI] [PubMed] [Google Scholar]
  20. Salerno Mariacarolina, Militerni Roberto, Bravaccio Carmela, Micillo Maria, Capalbo Donatella, Di Maio Salvatore, Tenore Alfred. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism. Thyroid. 2002 Jan;12(1):45–52. doi: 10.1089/105072502753451968. [DOI] [PubMed] [Google Scholar]
  21. Simons W. F., Fuggle P. W., Grant D. B., Smith I. Educational progress, behaviour, and motor skills at 10 years in early treated congenital hypothyroidism. Arch Dis Child. 1997 Sep;77(3):219–222. doi: 10.1136/adc.77.3.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Song S. I., Daneman D., Rovet J. The influence of etiology and treatment factors on intellectual outcome in congenital hypothyroidism. J Dev Behav Pediatr. 2001 Dec;22(6):376–384. doi: 10.1097/00004703-200112000-00005. [DOI] [PubMed] [Google Scholar]
  23. Sénécal J., Grosse M. C., Vincent A., Simon J., Lefrèche J. N. Maturation osseuse du foetus et du nouveau-né. Arch Fr Pediatr. 1977 May;34(5):424–438. [PubMed] [Google Scholar]
  24. Van Vliet G. Neonatal hypothyroidism: treatment and outcome. Thyroid. 1999 Jan;9(1):79–84. doi: 10.1089/thy.1999.9.79. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES